Principal Financial Group Portfolio holdings
Principal Financial Group, founded in 1879 as the Bankers Life Association by Edward Temple and headquartered in Des Moines, Iowa, is a global financial services firm specializing in retirement solutions, insurance, and asset management, overseeing more than $709 billion in assets under management as of late 2024. Serving over 62 million customers across individuals, businesses, and institutions, Principal offers 401(k) plans, group insurance (life, disability, dental), annuities, and investment products through its Principal Global Investors arm, with a strong focus on U.S. and international markets like Asia and Latin America. Known for its stability and customer-centric approach, the publicly traded company (NASDAQ: PFG) under CEO Dan Houston has expanded through acquisitions like Wells Fargo’s retirement business in 2019, emphasizing long-term financial security. With a workforce of over 19,000 and a legacy of resilience, Principal remains a trusted name in retirement and wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
|
+$437M |
| 2 |
Americold
COLD
|
+$218M |
| 3 |
Canadian Natural Resources
CNQ
|
+$165M |
| 4 |
Realty Income
O
|
+$134M |
| 5 |
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equity Lifestyle Properties
ELS
|
+$262M |
| 2 |
Franco-Nevada
FNV
|
+$163M |
| 3 |
Moody's
MCO
|
+$150M |
| 4 |
CubeSmart
CUBE
|
+$140M |
| 5 |
TransUnion
TRU
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.47% |
| 2 | Real Estate | 15.68% |
| 3 | Financials | 15.55% |
| 4 | Consumer Discretionary | 11.35% |
| 5 | Industrials | 11.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Arbutus Biopharma
ABUS
$861M
| $114K | ﹤0.01% |
45,575
-25
| -0.1% | -$49 |
|
|
MRC
2252
DELISTED
MRC Global
MRC
| $114K | ﹤0.01% |
10,348
-775
| -7% | -$8.12K |
|
2253
FuboTV Inc
FUBO
$283M
| $114K | ﹤0.01% |
2,979
-493
| -14% | -$17.1K |
|
2254
Ecovyst
ECVT
$1.32B
| $113K | ﹤0.01% |
11,599
-1,618
| -12% | -$15.4K |
|
2255
P3 Health Partners
PIII
$33.3M
| $113K | ﹤0.01% |
1,607
+6
| +0.4% | +$414 |
|
|
DHC
2256
Diversified Healthcare Trust
DHC
$2.13B
| $113K | ﹤0.01% |
30,122
-5,546
| -16% | -$13K |
|
|
CDMO
2257
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $112K | ﹤0.01% |
17,205
-325,301
| -95% | -$2.1M |
|
2258
Emergent Biosolutions
EBS
$382M
| $112K | ﹤0.01% |
46,551
+7,263
| +18% | +$17.1K |
|
2259
American Vanguard Corp
AVD
$70.4M
| $111K | ﹤0.01% |
10,131
-141,955
| -93% | -$1.41M |
|
2260
Allogene Therapeutics
ALLO
$635M
| $111K | ﹤0.01% |
34,613
-231,541
| -87% | -$657K |
|
2261
Navitas Semiconductor
NVTS
$3.01B
| $111K | ﹤0.01% |
13,754
-1,713
| -11% | -$11.5K |
|
|
INFN
2262
DELISTED
Infinera Corporation Common Stock
INFN
| $110K | ﹤0.01% |
23,065
+2,011
| +10% | +$7.91K |
|
2263
Nordic American Tanker
NAT
$1.36B
| $109K | ﹤0.01% |
26,033
-4,311
| -14% | -$18.3K |
|
2264
Cullinan Oncology
CGEM
$999M
| $109K | ﹤0.01% |
10,692
-181
| -2% | -$1.6K |
|
2265
Nano X Imaging
NNOX
$76.6M
| $108K | ﹤0.01% |
17,008
-1,128
| -6% | -$7.04K |
|
|
LAZR
2266
DELISTED
Luminar Technologies
LAZR
| $107K | ﹤0.01% |
2,110
+193
| +10% | +$9.59K |
|
2267
Phathom Pharmaceuticals
PHAT
$726M
| $106K | ﹤0.01% |
11,585
-216
| -2% | -$1.86K |
|
2268
NovaGold Resources
NG
$2.61B
| $105K | ﹤0.01% |
28,123
+2,596
| +10% | +$9.74K |
|
2269
Xeris Biopharma Holdings
XERS
$1.4B
| $105K | ﹤0.01% |
44,725
+1,601
| +4% | +$2.96K |
|
2270
Nkarta
NKTX
$154M
| $104K | ﹤0.01% |
15,793
+1,288
| +9% | +$3.34K |
|
|
YMAB
2271
DELISTED
Y-mAbs Therapeutics
YMAB
| $101K | ﹤0.01% |
14,829
-390
| -3% | -$2.26K |
|
2272
AngioDynamics
ANGO
$627M
| $101K | ﹤0.01% |
12,863
-548
| -4% | -$3.8K |
|
|
ESPR
2273
DELISTED
Esperion Therapeutics
ESPR
| $101K | ﹤0.01% |
33,633
-803
| -2% | -$1.04K |
|
2274
Fate Therapeutics
FATE
$291M
| $100K | ﹤0.01% |
26,787
-1,745
| -6% | -$4.12K |
|
2275
Ocular Therapeutix
OCUL
$1.84B
| $97.9K | ﹤0.01% |
21,959
-112
| -0.5% | -$331 |
|
Similar funds
Principal Financial Group's Q4 2023 Portfolio in Review
As of Q4 2023, Principal Financial Group held 2,491 positions worth $157B, up 13% from $139B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Principal Financial Group's Q4 2023 filing shows 55 new, 722 increased, 1,607 reduced and 73 closed positions. Its largest new stake was Veralto: 341,316 shares worth $28.1M. The largest sale was Equity Lifestyle Properties, an estimated $262M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Financials.
- Principal Financial Group's largest Q4 2023 buy was Veralto: 341,316 shares worth $28.1M.
- Principal Financial Group added most to Principal Exchange-Traded Funds Principal US Mega-Cap ETF in Q4 2023, an estimated $437M increase.
- Principal Financial Group's biggest Q4 2023 reduction was Equity Lifestyle Properties, cutting an estimated $262M.
- Principal Financial Group fully exited Activision Blizzard in Q4 2023, selling an estimated $77.2M.
- Principal Financial Group's ten largest holdings make up 17% of its $157B portfolio in Q4 2023.
- Principal Financial Group opened 55 new positions and closed 73 in Q4 2023.
- Principal Financial Group's portfolio value rose 13% quarter-over-quarter to $157B.
Based on Principal Financial Group's 13F filing for Q4 2023, filed 7 Feb 2024.